Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.

Area of Science:

• Biotechnology
• Molecular Biology
• Virology

Background:

• Adeno-associated virus (AAV) is a promising vector for gene therapy due to its non-pathogenicity, long-term infection, and broad tropism.
• Over 100 AAV serotypes exist, differing in capsid protein amino acid sequences, influencing cellular entry and tropism.
• AAV infection involves endocytosis, nuclear transport, and interaction with proteoglycans as primary receptors, with varying sugar chain binding specificities.

Purpose of the Study:

• To emphasize the necessity of comprehensive evaluation for AAV-based biopharmaceuticals.
• To highlight the importance of understanding receptor-ligand interactions for enhanced gene therapy safety and efficacy.
• To identify key areas for improving AAV vector technology for therapeutic applications.

Main Methods:

• Analysis of AAV capsid protein structures, including amino acid sequences and post-translational modifications like glycosylation.
• Evaluation of the higher-order protein structure, such as capsid folding and 3D functional domain structures.
• Investigation of proteoglycan receptor binding specificities and their role in AAV cellular uptake.

Main Results:

• The study underscores that detailed structural analysis of AAV capsid proteins and host cell receptors is critical.
• Differences in proteoglycan sugar chains significantly impact AAV binding and cellular entry.
• Understanding these molecular interactions is key to optimizing AAV vector performance.

Conclusions:

• Comprehensive structural and functional evaluation of AAV components and their receptors is essential for ensuring the safety and efficacy of gene therapy products.
• Improving gene transfer efficiency, reducing vector dosage, and preventing off-target infections are crucial for advancing AAV-based therapies.
• Further research into AAV-receptor interactions will facilitate the development of next-generation gene therapy vectors.